|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.320 USD | +0.87% |
|
+0.87% | +28.89% |
| 05-13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | 11 | +374.14% | 2 | |||||
| 1,220.39 | +0.53% | 28 | ||||||
| 257.5 | -2.11% | 22 | ||||||
| 256.14 | -1.89% | 28 | ||||||
| 358.94 | +5.39% | 18 | ||||||
| 217.82 | +12.83% | 22 | ||||||
| 154.03 | -3.26% | 21 | ||||||
| 315.66 | -3.44% | 24 | ||||||
| 354.76 | -5.18% | 29 | ||||||
| 157.67 | +20.11% | 27 | ||||||
| 29.15 | +19.86% | 27 | ||||||
| 548.69 | +3.91% | 29 | ||||||
| 63 | +8.38% | 24 | ||||||
| 20.95 | +3.99% | 19 | ||||||
| 96.7 | +27.56% | 23 | ||||||
| 10,006.67 | +30.94% | 15 | ||||||
| 52.47 | -1.66% | 18 | ||||||
| 81.14 | +49.02% | 16 | ||||||
| 6,106.87 | +13.96% | 15 | ||||||
| Average | 1,068.92 | +29.11% | 21 | ||||||
| Weighted average by Cap. | 706.54 | +3.93% | 24 |
- Stock Market
- Stocks
- PLX Stock
- Sector Protalix BioTherapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
